PT  - JOURNAL ARTICLE
AU  - Spigel, David R
AU  - Hamilton, Erika
AU  - Bashir, Babar
AU  - Gergis, Usama
AU  - Murthy, Hemant S
AU  - Chumsri, Saranya
AU  - Migdady, Yazan
AU  - Specht, Jennifer
AU  - Chaudhary, Lubna N
AU  - Garber, Haven
AU  - Kim, Chul
AU  - Mamdani, Hirva
AU  - Fitzsimmons, Sarah
AU  - Ganguly, Bishwa J
AU  - Hiraragi, Hajime
AU  - Jensen, Helle
AU  - Kim, Yeonhee
AU  - Lessig, Mary C
AU  - Gillenwater, Heidi
TI  - 754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)
AID  - 10.1136/jitc-2023-SITC2023.0754
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A850--A850
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A850.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A850.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.